Full text of Trump's executive order on 7-nation ban,
Full text of Trump's executive order on 7-nation ban, refugee suspension
01/28/2017 - 10:01am
Trump signed an executive order Friday evening making significant changes to the visa and refugee programs in the United States. It includes:
Cuts the number of refugees allowed into the United States in fiscal 2017 from 110,000 to 50,000
Suspends for 120 days the U.S. Refugee Admissions Program, which identifies and processes refugees for resettlement in the United States
Suspends the entry of all “immigrants and nonimmigrants” from Iraq, Iran, Sudan and Libya for a period of 90 days. This may also apply to citizens of Libya, Yemen and Somalia depending on the interpretation.
Bars all Syrian refugees for an indefinite period
Directs the secretary of homeland security, the director of national intelligence and secretary of state to put together a list of countries that do not provide adequate information to vet potential entry of foreign nationals into the United States. Foreign nationals from those countries will be banned from entering the United States.
Directs the secretary of state, the secretary of homeland security, the director of national intelligence, and the director of the FBI to implement uniform screening standards for all immigration programs
Directs the secretary of homeland security, upon the resumption of the U.S. Refugee Admissions Program, to “prioritize refugee claims made by individuals on the basis of religious-based persecution, provided that the religion of the individual is a minority religion in the individual's country of nationality.”
Directs the secretary of homeland security to implement a biometric entry-exit tracking system
Grants state and local jurisdictions, whenever possible a “role in the process of determining the placement or settlement” of refugees
Suspend the Visa Interview Waiver Program, which allows certain people renewing their visas to skip an in-person interview
Directs the secretary of state to expand the Consular Fellows Program
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
Top 5 Most Recently Viewed Articles
Volvo's Shift Away from LiDAR Technology Recently, the Swedish automaker Volvo announced its decision to cease its partnership with Luminar Technologies Inc. (NASDAQ: LAZR). This bold move has caught the attention of the automotive industry, especially those tracking advancements in autonomous vehicle technology. By not integrating LiDAR technology into its forthcoming...
Continue Reading
Samsung and Xiaomi Face Antitrust Investigation in India Samsung, Xiaomi, and various other smartphone manufacturers are under serious scrutiny for allegedly colluding with major e-commerce platforms in India, undermining fair market practices. The Competition Commission of India (CCI) has gathered evidence that suggests these companies coordinated with Amazon and...
Continue Reading
Bonnie Navin Attributes and Accolades Bonnie Navin of Rubenstein Law has recently earned a significant honor by being selected as a member of the Medical Malpractice Trial Lawyers Association - Top 25. This elite recognition is awarded to the most distinguished attorneys specializing in medical malpractice across the nation, and it showcases Navin's exceptional skill and...
Continue Reading
Success in the business world has never been a cakewalk. Many new ventures stumble within a decade, and only a handful manage to stay afloat while also boasting a robust and growing dividend program. Companies that consistently dish out dividends reflect financial health, but there’s more to the story. Take Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE:...
Continue Reading
Cathie Wood's Deflationary Boom Forecast Amid Market Turbulence CEO of Ark Funds, Cathie Wood, has made bold predictions regarding a potential "deflationary boom" despite significant losses in the stock market. Recent trading sessions saw renowned tech stocks, collectively known as the Magnificent Seven, lose about $780 billion in market capitalization in a single day,...
Continue Reading